Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 10.89M | $46.0M | 15.59% | -- | 2026-06-30 |
| Fcpm III Services B.V. | 3.47M | $14.0M | 4.97% | -- | 2026-06-30 |
| Armistice Capital, LLC | 3.40M | $14.0M | 4.87% | -- | 2026-06-30 |
| Long Focus Capital Management, LLC | 3.31M | $14.0M | 4.74% | -- | 2026-06-30 |
| Renaissance Technologies LLC | 1.53M | $6.0M | 2.20% | +554.1K | 2026-06-30 |
| GSK plc | 1.53M | $6.0M | 2.19% | -- | 2026-06-30 |
| Price T Rowe Associates Inc | 902.1K | $3.0M | 1.29% | -126.1K | 2026-06-30 |
| Marshall Wace, LLP | 797.9K | $3.0M | 1.14% | +420.6K | 2026-06-30 |
| Qube Research & Technologies Ltd | 775.6K | $3.0M | 1.11% | +466.9K | 2026-06-30 |
| Morgan Stanley | 667.3K | $2.0M | 0.96% | +48.9K | 2026-06-30 |
